{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:54:11Z","timestamp":1762221251582,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Gansu Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["22JR5RA680","25JRRA311"],"award-info":[{"award-number":["22JR5RA680","25JRRA311"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.transproceed.2025.02.025","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:45:40Z","timestamp":1741826740000},"page":"529-537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and Validation of a Nomogram for Predicting Subtherapeutic Tacrolimus Blood Levels in Renal Transplant Recipients: A Multivariate Logistic Regression Analysis"],"prefix":"10.1016","volume":"57","author":[{"given":"Bowen","family":"Duan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.transproceed.2025.02.025_bib0001","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cpt.113","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing","volume":"98","author":"Birdwell","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2025.02.025_bib0002","doi-asserted-by":"crossref","first-page":"717148","DOI":"10.3389\/fphar.2021.717148","article-title":"Case report: low hematocrit leading to tacrolimus toxicity","volume":"12","author":"Piletta-Zanin","year":"2021","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.transproceed.2025.02.025_bib0003","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/cpt.1618","article-title":"Intrapatient variability of tacrolimus exposure in solid organ transplantation: a novel marker for clinical outcome","volume":"107","author":"Kuypers","year":"2020","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.transproceed.2025.02.025_bib0004","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.transproceed.2022.02.018","article-title":"Renal Cyp3a5-expressing genotype decreases tacrolimus-to-dose ratio in small cohort of renal transplant recipients-preliminary report","volume":"54","author":"Warzyszy\u0144ska","year":"2022","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.transproceed.2025.02.025_bib0005","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/jcpt.13579","article-title":"Machine learning-based method for tacrolimus dose predictions in Chinese kidney transplant perioperative patients","volume":"47","author":"Fu","year":"2022","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.transproceed.2025.02.025_bib0006","doi-asserted-by":"crossref","unstructured":"Yanjun ZHOU, Wang Chunli, Chi Wei, et al. Construction of a Nomogram Risk Prediction Model for Acute Cardiotoxicity Associated with Anthracycline Drugs in Pediatric Hematological Tumors: a retrospective cohort study in China, 25 March 2024, PREPRINT (Version 1) available at Research Square.","DOI":"10.21203\/rs.3.rs-4119637\/v1"},{"key":"10.1016\/j.transproceed.2025.02.025_bib0007","article-title":"Improving prediction of tacrolimus concentration using a combination of population pharmacokinetic modeling and machine learning in Chinese renal transplant recipients","volume":"15","author":"Wang","year":"2024","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.transproceed.2025.02.025_bib0008","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00228-022-03445-5","article-title":"Application of machine learning to predict tacrolimus exposure in liver and kidney transplant patients given the MeltDose formulation","volume":"79","author":"Ponthier","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2025.02.025_bib0009","article-title":"A prediction model for tacrolimus daily dose in kidney transplant recipients with machine learning and deep learning techniques","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.transproceed.2025.02.025_bib0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13318-021-00735-8","article-title":"Predictive performance of published tacrolimus population pharmacokinetic models in Thai kidney transplant patients","volume":"47","author":"Methaneethorn","year":"2022","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"3","key":"10.1016\/j.transproceed.2025.02.025_bib0011","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.transproceed.2025.02.025_bib0012","article-title":"Therapeutic drug monitoring of tacrolimus after kidney transplantation: trough concentration or area under curve-based monitoring?","volume":"6","author":"van Gelder","year":"2024","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2025.02.025_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1000476","article-title":"Commentary: predicting blood concentration of tacrolimus in patients with autoimmune diseases using machine learning techniques based on real-world evidence","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.transproceed.2025.02.025_bib0014","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3390\/biomedicines12051125","article-title":"The influence of tacrolimus exposure and metabolism on the outcomes of kidney transplants","volume":"12","author":"Maslauskiene","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.transproceed.2025.02.025_bib0015","doi-asserted-by":"crossref","unstructured":"Monchal Q, Mariat C, Maillard N, Claisse G. Impact of tacrolimus peak concentration on kidney graft outcomes. Nephrol Dial Transplant. 2024;39(suppl 1):gfae069-0180-2462. doi:10.1093\/ndt\/gfae069.180.","DOI":"10.1093\/ndt\/gfae069.180"},{"issue":"1","key":"10.1016\/j.transproceed.2025.02.025_bib0016","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.transproceed.2022.12.004","article-title":"A low tacrolimus concentration-to-dose ratio increases calcineurin inhibitor nephrotoxicity and cytomegalovirus infection risks in kidney transplant recipients: a single-center study in Japan","volume":"55","author":"Tomizawa","year":"2023","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2025.02.025_bib0017","doi-asserted-by":"crossref","first-page":"3129389","DOI":"10.1155\/2022\/3129389","article-title":"Tacrolimus concentration is effectively predicted using combined clinical and genetic factors in the perioperative period of kidney transplantation and associated with acute rejection","volume":"2022","author":"Cheng","year":"2022","journal-title":"J Immunol Res"},{"issue":"6","key":"10.1016\/j.transproceed.2025.02.025_bib0018","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/clinchem\/hvac064","article-title":"Commentary on perplexingly high tacrolimus concentrations in a renal transplant patient with HIV","volume":"68","author":"Heger","year":"2022","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.transproceed.2025.02.025_bib0019","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/bcp.14585","article-title":"Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients","volume":"87","author":"Francke","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2025.02.025_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clinbiochem.2021.12.002","article-title":"Monitoring intracellular tacrolimus concentrations and its relationship with rejection in the early phase after renal transplantation","volume":"101","author":"Francke","year":"2022","journal-title":"Clin Biochem"},{"issue":"1","key":"10.1016\/j.transproceed.2025.02.025_bib0021","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/fcp.12412","article-title":"Tacrolimus diffusion across the peripheral mononuclear blood cell membrane: impact of drug transporters","volume":"33","author":"Tron","year":"2019","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.transproceed.2025.02.025_bib0022","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/FTD.0000000000001201","article-title":"Tacrolimus Monitoring in Liver Transplant Recipients, Posttransplant Cholestasis: A Comparative Between 2 Commercial Immunoassays and a Liquid Chromatography-Tandem Mass Spectrometry Method","volume":"46","author":"Parant","year":"2024","journal-title":"Ther Drug Monit"},{"issue":"10","key":"10.1016\/j.transproceed.2025.02.025_bib0023","article-title":"Effects of cholestasis on whole blood concentration of tacrolimus, an immunosuppressant, in living-related liver transplant recipients","volume":"4","author":"Kobuchi","year":"2013","journal-title":"Int J Phys Med Rehabil"},{"issue":"1","key":"10.1016\/j.transproceed.2025.02.025_bib0024","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13256-024-04394-6","article-title":"Tacrolimus-induced cholestatic hepatotoxicity after renal transplantation: a case report","volume":"18","author":"Pourrezagholi","year":"2024","journal-title":"J Med Case Rep"},{"issue":"9","key":"10.1016\/j.transproceed.2025.02.025_bib0025","first-page":"1422","article-title":"Relationship between serum creatinine and tacrolimus clearance in renal transplant patients","volume":"32","author":"V\u00e1zquez","year":"2013","journal-title":"Lat Am J Pharm"},{"key":"10.1016\/j.transproceed.2025.02.025_bib0026","doi-asserted-by":"crossref","unstructured":"Rotarescu CA, Maruntelu I, Rotarescu I, Constantinescu AE, Constantinescu I. Single Nucleotide Polymorphisms of CYP3A4 and CYP3A5 in Romanian Kidney Transplant Recipients: Effect on Tacrolimus Pharmacokinetics in a Single-Center Experience. J Clin Med. 2024;13(7):1968.","DOI":"10.3390\/jcm13071968"},{"issue":"5","key":"10.1016\/j.transproceed.2025.02.025_bib0027","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3390\/ph17050553","article-title":"Effects of CYP3A5 Genotype on Tacrolimus Pharmacokinetics and Graft-versus-Host Disease Incidence in Allogeneic Hematopoietic Stem Cell Transplantation","volume":"17","author":"Marco","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.transproceed.2025.02.025_bib0028","doi-asserted-by":"crossref","unstructured":"Rotarescu CA, Maruntelu I, Rotarescu I, Constantinescu AE, Constantinescu I. Single Nucleotide Polymorphisms of CYP3A4 and CYP3A5 in Romanian Kidney Transplant Recipients: Effect on Tacrolimus Pharmacokinetics in a Single-Center Experience. J Clin Med. 2024;13(7):1968.","DOI":"10.3390\/jcm13071968"},{"key":"10.1016\/j.transproceed.2025.02.025_bib0029","article-title":"CYP3A4*18B, CYP3A5*3, and MDR1C3435T gene studies with tacrolimus pharmacokinetics in healthy Chinese subjects","volume":"13","author":"Yin","year":"2024","journal-title":"Authorea"},{"issue":"1","key":"10.1016\/j.transproceed.2025.02.025_bib0030","doi-asserted-by":"crossref","first-page":"16502","DOI":"10.1038\/s41598-023-43755-x","article-title":"Association of high intra-patient variability in tacrolimus exposure with calcineurin inhibitor nephrotoxicity in kidney transplantation","volume":"13","author":"Kim","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.transproceed.2025.02.025_bib0031","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cca.2022.08.014","article-title":"The clinical validation of a dried blood spot method for simultaneous measurement of cyclosporine A, tacrolimus, creatinine, and hematocrit","volume":"535","author":"Francke","year":"2022","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.transproceed.2025.02.025_bib0032","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ndt\/gfae119","article-title":"Calcineurin inhibitor effects on kidney electrolyte handling and blood pressure: tacrolimus versus voclosporin","volume":"40","author":"Wei","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.transproceed.2025.02.025_bib0033","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3390\/biomedicines12051125","article-title":"The Influence of Tacrolimus Exposure and Metabolism on the Outcomes of Kidney Transplants","volume":"12","author":"Maslauskiene","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.transproceed.2025.02.025_bib0034","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/jcm10010141","article-title":"Progression of Interstitial Fibrosis and Tubular Atrophy in Low Immunological Risk Renal Transplants Monitored by Sequential Surveillance Biopsies: The Influence of TAC Exposure and Metabolism","volume":"10","author":"Chamoun","year":"2021","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.transproceed.2025.02.025_bib0035","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14879","article-title":"Exposure to tacrolimus trough levels below 6 ng\/ml during the first year is associated with inferior kidney graft survival","volume":"37","author":"Agur","year":"2023","journal-title":"Clin Transplant"},{"issue":"9S","key":"10.1016\/j.transproceed.2025.02.025_bib0036","article-title":"311.1: real-life tacrolimus levels are associated with biopsy-proven acute rejection after the first year post-kidney transplantation","volume":"106","author":"Soufian","year":"2022","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.transproceed.2025.02.025_bib0037","doi-asserted-by":"crossref","first-page":"S350","DOI":"10.1016\/j.ekir.2022.01.851","article-title":"POS-815 an exploratory study on tacrolimus time-in-therapeutic range (TTR) among kidney allograft recipients in a Malaysian tertiary care hospital","volume":"7","author":"Malar","year":"2022","journal-title":"Kidney Int Rep"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134525001289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134525001289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:51:48Z","timestamp":1762221108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134525001289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0041134525001289"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2025.02.025","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and Validation of a Nomogram for Predicting Subtherapeutic Tacrolimus Blood Levels in Renal Transplant Recipients: A Multivariate Logistic Regression Analysis","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2025.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}